PatientMatch — Privacy-first clinical trial discovery

189 trials

Solid TumorRecruiting now

Enrolling now24

Nationwide

MK-4716-001 Clinical Trial

Merck Sharp & Dohme LLC

Ph 1·~5yr·3 sites in NJ, TX, VA

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A First-in-human Trial of BGB-53038

BeiGene

Ph 1·~2yr·4 sites in CA, KS, MD +1

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Qurgen Inc.

Ph 1·~3yr·5 sites in AZ, MI, NC +2

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Phase 1/2 Trial of TER-2013

Terremoto Biosciences Inc.

Ph 1/2·~3yr·14 sites in FL, MA, MN +9

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

BeOne Medicines

Ph 1·~4yr·8 sites in CA, CT, FL +4

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

BridGene Biosciences Inc.

Ph 1·~4yr·1 site in TX

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of JZP815 Oral Capsules

Jazz Pharmaceuticals

Ph 1·~5yr·14 sites in CO, FL, IL +6

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Merck Sharp & Dohme LLC

Ph 2·~2yr·7 sites in AK, FL, LA +3

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study of Neladalkib (NVL-655)

Nuvalent Inc.

Ph 1/2·~6yr·21 sites in CA, CO, DC +14

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Nuvalent Inc.

Ph 1·~1.5yr·17 sites in CA, CO, DC +11

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

A Study of ETX-19477 in Patients With Advanced Solid Malignancies

858 Therapeutics, Inc.

Ph 1/2·~3yr·14 sites in AZ, CT, FL +10

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Merck Sharp & Dohme LLC

Ph 1/2·~6yr·17 sites in CA, CO, CT +13

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)

Daiichi Sankyo

Ph 2·~3yr·8 sites in GA, MI, NJ +3

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Turning Point Therapeutics, Inc.

Ph 1/2·~8yr·20 sites in CA, CO, FL +12

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Memorial Sloan Kettering Cancer Center

Ph 2·~6yr·15 sites in CA, DC, GA +6

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

Exelixis

Ph 1·~3yr·10 sites in CA, CT, FL +6

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of Zidesamtinib (NVL-520)

Nuvalent Inc.

Ph 1/2·~7yr·20 sites in CA, CO, DC +13

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

A Study to Assess IPN01194 in Adults With Advanced Solid Tumours

Ipsen

Ph 1/2·~4yr·5 sites in CA, CT, TN +1

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Merck Sharp & Dohme LLC

Ph 1/2·~6yr·4 sites in AL, FL, NJ +1

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate RO7566802

Genentech, Inc.

Ph 1·~4yr·6 sites in AL, CT, NY +3

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

iPhone Weight Loss App Trial

Jonsson Comprehensive Cancer Center

Lifestyle·~7yr·1 site in CA

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NiKang Therapeutics, Inc.

Ph 1·~5yr·19 sites in AR, CA, CO +10

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Novartis Pharmaceuticals

Ph 3·~3yr·6 sites in CA, FL, IL +2

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Physical Activity and Survival in Advanced Cancer

M.D. Anderson Cancer Center

Device·~16yr·1 site in TX

Enrolling now

12q~3min

Check if I qualify View study